Par Stands By “Authorized” Generics; “More Creative” Deals Coming
Executive Summary
Drug patent dispute settlements are likely to become more "creative" in the future, Par CEO Scott Tarriff says
You may also be interested in...
Par Acquires Kali Labs, Expects To Market 50% More Products In Two Years
Par Pharmaceutical's acquisition of Kali will help the firm increase its number of marketed generic drugs from 72 to at least 108 by the end of 2005, the company said
Par Acquires Kali Labs, Expects To Market 50% More Products In Two Years
Par Pharmaceutical's acquisition of Kali will help the firm increase its number of marketed generic drugs from 72 to at least 108 by the end of 2005, the company said
Watson/P&G Macrobid “Authorized” Generic Challenged By Mylan
Mylan argues an "authorized" generic agreement between Watson and Procter & Gamble for a version of Macrobid inhibits competition